Use of Omega-3s in Traumatic Brain Injury

Michael D Lewis

Brain Health Education and Research Institute, USA

^*Correspondance to: Michael D Lewis 

 PDF  Full Text DOI: 10.25107/2474-1647.1449

Abstract

Clinical studies thus far have failed to identify an effective treatment strategy for Traumatic brain injury (TBI), when a combination of targets controlling aspects of neuroprotection, neuroinflammation, and neuroregeneration is needed. Omega-3 fatty acids (n-3FA) offer the advantage of this approach. Although further clinical trial research is needed, there is a growing body of strong preclinical evidence and clinical experience which suggests that benefits may be possible from aggressively adding substantial amounts of n-3FA to optimize the nutritional foundation of TBI, concussion, and post-concussion syndrome patients. Early and optimal doses of n-3FA, even in a preventive setting, have the potential to improve outcomes without significant side-effects. With evidence of unsurpassed safety and tolerability, n-3FA should be considered in the acute care and surgical setting, if conventional medicine can overcome its inherent bias against nutritional, non-pharmacologic therapies.

Keywords

Omega-3; Decosahexanoic acid; DHA; TBI; Brain injury; Concussion; Neuroregeneration; Neuroinflammation; Neuroprotection

Cite the article

Lewis MD. Use of Omega-3s in Traumatic Brain Injury. Clin Surg. 2017; 2: 1449.